AcornHRD: an HRD algorithm highly associated with anthracycline-based neoadjuvant chemotherapy in breast cancer in China.

MLA

Pan, Jia-Ni, et al. “AcornHRD: An HRD Algorithm Highly Associated with Anthracycline-Based Neoadjuvant Chemotherapy in Breast Cancer in China.” European Journal of Medical Research, vol. 29, no. 1, July 2024, p. 366. EBSCOhost, https://doi.org/10.1186/s40001-024-01936-y.

APA

Pan, J.-N., Li, P.-C., Wang, M., Li, M.-W., Ding, X.-W., Zhou, T., Wang, H.-N., Wang, Y.-K., Chen, L.-B., Wang, R., Ye, W.-W., Wu, W.-Z., Lou, F., Wang, X.-J., & Cao, W.-M. (2024). AcornHRD: an HRD algorithm highly associated with anthracycline-based neoadjuvant chemotherapy in breast cancer in China. European Journal of Medical Research, 29(1), 366. https://doi.org/10.1186/s40001-024-01936-y

Chicago

Pan, Jia-Ni, Pu-Chun Li, Meng Wang, Ming-Wei Li, Xiao-Wen Ding, Tao Zhou, Hui-Na Wang, et al. 2024. “AcornHRD: An HRD Algorithm Highly Associated with Anthracycline-Based Neoadjuvant Chemotherapy in Breast Cancer in China.” European Journal of Medical Research 29 (1): 366. doi:10.1186/s40001-024-01936-y.